Date: 2017-03-20
Type of information: Nomination
Compound: Chief Technology and Manufacturing Officer, Senior Vice President, Corporate Development and Strategy.
Company: Bluebird bio (USA - MA)
Therapeutic area: Rare diseases - Genetic diseases
Type agreement: nomination
Action mechanism:
Disease:
Details:
- • On March 20, 2017, bluebird bio announced that Derek Adams is joining the company as its Chief Technology and Manufacturing Officer and Joanne Smith-Farrell, Ph.D., is joining as Senior Vice President, Corporate Development and Strategy.
- Dr. Adams comes to bluebird from Evelo Biosciences, where he was the Senior Vice President of CMC. At Evelo, Dr. Adams established the initial process development function and supply chain for clinical studies and drove strategy for product development in conjunction with other members of the company’s leadership team. Prior to his time at Evelo, Dr. Adams served as Vice President of Technical and Strategic Product Development at Alexion Pharmaceuticals, where his responsibilities included developing and supporting all manufacturing processes globally.
- Dr. Smith-Farrell joins bluebird bio from Merck&Co where she was Vice President, Business Development Transactions. At Merck, Dr. Smith-Farrell led the team that structured, negotiated, and executed Business Development Transactions supporting Merck Research Labs. Prior to Merck, Dr. Smith-Farrell was Vice President of Strategic Transactions at Pfizer.
Financial terms:
Latest news:
Is general: Yes
